We know that when you battle prostate cancer, there are often more questions than answers. DNA may be the key to unlocking some of those answers. That’s why we’ve started PROMISE.

PROMISE is a new research study led by Dr. Heather Cheng at the University of Washington and Dr. Channing Paller at Johns Hopkins University, with funding and support provided by Advancing Cancer Treatment (ACT). Vital contributions are also provided by the Prostate Cancer Clinical Trials Consortium (PCCTC).

Together with genetic counselors, researchers, physicians, caregivers, and patients, we are a coalition dedicated to uncovering new treatments and providing answers for you, your family, and men everywhere.